Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.19−0.08 (-2.45%)
Close on Nov 17, 2026Market cap $1.18BP/E 15.9Yield –
Cronos operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cronos's operating cash flow for the twelve months ending Jun 30, 2026 was $60.05M, up 199.9% year over year. For fiscal 2025 it was $25.87M, up 37.3% from the year before. The highest annual figure on record is $25.87M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.87M | +37.3% |
| FY2024 | Dec 31, 2024 | $18.84M | – |
| FY2023 | Dec 31, 2023 | -$42.84M | – |
| FY2022 | Dec 31, 2022 | -$88.95M | – |
| FY2021 | Dec 31, 2021 | -$153.62M | – |
| FY2020 | Dec 31, 2020 | -$144.87M | – |
| FY2019 | Dec 31, 2019 | -$131.19M | – |
| FY2018 | Dec 31, 2018 | -$7.52M | – |
| FY2017 | Dec 31, 2017 | -$4.28M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $24.01M | +752.0% |
| Q1 FY2026 | Mar 31, 2026 | $10.90M | – |
| Q4 FY2025 | Dec 31, 2025 | $11.84M | +53.3% |
| Q3 FY2025 | Sep 30, 2025 | $13.31M | +14.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.82M | +61.6% |
| Q1 FY2025 | Mar 31, 2025 | -$2.10M | – |
| Q4 FY2024 | Dec 31, 2024 | $7.72M | -54.1% |
| Q3 FY2024 | Sep 30, 2024 | $11.58M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.74M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.20M | – |
| Q4 FY2023 | Dec 31, 2023 | $16.82M | – |
| Q3 FY2023 | Sep 30, 2023 | -$183.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.77M | – |
| Q1 FY2023 | Mar 31, 2023 | -$47.69M | – |
| Q4 FY2022 | Dec 31, 2022 | -$24.37M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.39M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.28M | – |
| Q1 FY2022 | Mar 31, 2022 | -$33.91M | – |
| Q4 FY2021 | Dec 31, 2021 | -$35.94M | – |
| Q3 FY2021 | Sep 30, 2021 | -$31.48M | – |
| Q2 FY2021 | Jun 30, 2021 | -$39.58M | – |
| Q1 FY2021 | Mar 31, 2021 | -$46.62M | – |
| Q4 FY2020 | Dec 31, 2020 | -$38.33M | – |
| Q3 FY2020 | Sep 30, 2020 | -$28.17M | – |
| Q2 FY2020 | Jun 30, 2020 | -$39.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$38.90M | – |
| Q4 FY2019 | Dec 31, 2019 | -$54.40M | – |
| Q3 FY2019 | Sep 30, 2019 | -$20.02M | – |
| Q2 FY2019 | Jun 30, 2019 | -$42.93M | – |
| Q1 FY2019 | Mar 31, 2019 | -$13.84M | – |
See a number that looks wrong?